Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
Evaluation of Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
調査の概要
詳細な説明
The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.
In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.
Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.
Data collection is planned to take place in February-March 2021.
Surveys will be distributed via WhatsApp, e-mail, social media links. This questionnaire was sent to 3 physiotherapists and subjected to a pre-test. This questionnaire is about the following situations and contains 37 questions:
Information on employment status: In this section, physiotherapists' name-surname, gender, age, professional practice experience (years), generally applied physiotherapy subgroup (more than one can be selected), whether they are self-employed or employees, and the status of performing face-to-face clinical practices will be questioned. If so, it will be questioned which protection measures have been applied.
Information about tele-rehabilitation practices: In this section, it will be questioned whether physiotherapists start to follow their patients remotely, if they are, in what way they do it, whether the number of weekly sessions continues, and whether the amount collected is the same as the face-to-face amount.
General information about COVID 19 rehabilitation: In this section, did the departments where physiotherapists work returned to COVID 19 services, did they work in COVID 19 units, rehabilitation approaches in COVID 19 patients, protocol and / or guidelines on exercises for rehabilitation management and treatment of COVID 19 patients. material development / implementation status will be questioned.
The impact of the pandemic on the health and teaching activities of physiotherapists and the sustainability of clinical / thesis studies during this period will be questioned.
Finally, the CES Depression Scale (Center for Epidemiologic Studies Depression Scale, CES-D) will be used to determine depression level, the Generalized Anxiety Disorder 7 (GAD-7) Test will be used to evaluate generalized anxiety level, Perceived Stress Scale (PSS) will be used to determine stress level.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Beykoz
-
Istanbul、Beykoz、七面鳥、34815
- Medipol University
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
Exclusion Criteria:
Not meeting the inclusion criteria
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:コホート
- 時間の展望:回顧
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Physiotherapists
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
A questionnaire created by research physiotherapists based on researches and examples in the literature.
時間枠:The evaluation will take place in one interview (the interview will take 30 minutes)
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Assessment of depression level with Center for Epidemiologic Studies Depression Scale
時間枠:The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Center for Epidemiologic Studies Depression Scale will be used to determine depression level.
The scale consists of 20 questions in the form of a self-report that measure the emotional state of the person in depression, perceptions and behaviors towards depression.
4-point Likert type questionnaire with 0-60 points range is encoded in 0-3 points range.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of anxiety level with Generalized Anxiety Disorder 7 Test
時間枠:The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Generalized Anxiety Disorder 7 test will be used to determine anxiety level.
It is a 7-item four-point Likert (0 = none, 1 = many days, 2 = more than half of the days, 3 = almost every day), which evaluates the experiences asked in the scale items in the last 2 weeks.
The total scores obtained from the scale are 5, 10, and 15 cut-off points for mild, moderate, and severe anxiety, respectively.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of stress level with Perceived Stress Scale
時間枠:The evaluation will take place in one interview (the interview will take 30 minutes)
|
Perceived Stress Scale will be used to determine stress level.
Participants rate how often their lives were seen as unpredictable, uncontrollable, and overly intense during the previous month on the 5-point Likert scale (0 = Never, 4 = Very often).
Total scores range from 0 to 40, with higher scores indicating a higher perceived stress level.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
協力者と研究者
スポンサー
捜査官
- スタディチェア:Gülay Aras Bayram, asAss. Prof.、Medipol University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- E-10840098-772.02-2682
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
理学療法の臨床試験
-
Swansea University完了A Bite of ACT' (BOA) Acceptance and Commitment Therapy オンライン心理教育コース | 待機リスト コントロールイギリス
A questionnaire and scales.の臨床試験
-
Giancarlo Natalucci積極的、募集していない